The putative prostate cancer stem-like cell marker CD44 has been associated with prostate cancer stem like feature [46], and has been indicated to play an essential role in the quiescence of hematopoietic stem cells in the osteoblastic niche [50]. The gene discussed is CD44; the disease is prostate carcinoma.